Abstract:BACKGROUND:Systemic anaplastic large cell lymphoma (S-ALCL) is a rare disease with a highly variable prognosis and no standard chemotherapy regimen. Anaplastic lymphoma kinase (ALK) has been reported as an important prognostic factor correlated with S-ALCL in many but not all studies. In our study, we retrospectively analyzed 92 patients with S-ALCL from the Peking University Lymphoma Center for clinical and molecular prognostic factors to make clear the role of ALK and other prognostic factors in Han Chinese S-ALCL.RESULTS:The majority of Chinese S-ALCL patients were young male patients (median age 26, male/female ratio 1.7) and the median age was younger than previous reports regardless of ALK expression status. The only statistically significant different clinical characteristic in S-ALCL between ALK positive (ALK+) and ALK negative (ALK-) was age, with a younger median age of 22 for ALK+ compared with 30 for ALK-. However, when pediatric patients (≤ 18) were excluded, there was no age difference between ALK+ and ALK-. The groups did not differ in the proportion of males, those with clinical stage III/IV (49 vs 51%) or those with extranodal disease (53 vs 59%). Of 73 evaluable patients, the 3-year and 5-year survival rates were 60% and 47%, respectively. Univariate analysis showed that three factors: advanced stage III/IV, lack of expression of ALK, and high Ki-67 expression, were associated with treatment failure in patients with S-ALCL. However, ALK expression correlated with improved survival only in patients younger than 14 years, while not in adult patients. In multivariate analysis, only clinical stage was an independent prognostic factor for survival. Expressions of Wilms tumor 1 (WT1) and B-cell lymphoma 2 protein (BCL-2) correlated with the expression of ALK, but they did not have prognostic significance. High Ki-67 expression was also a poor prognostic factor.CONCLUSIONS:Our results show that ALK expression alone is not sufficient to determine the outcome of ALCL and other prognostic factors must be considered. Clinical stage is an independent prognostic factor. Ki-67 expression is a promising prognostic factor.

Expression of Alk Protein, Mrna and Fusion Transcripts in Anaplastic Large Cell Lymphoma

ALK-positive large B-cell lymphoma: a clinicopathological and molecular characteristics analysis of seven cases

[Alterations of ALK gene and protein expression in prostatic cancer and its clinical significance].

Anaplastic Lymphoma Kinase Gene Abnormality and the Expression of Its Fusion Protein in Primary Systemic Anaplastic Large Cell Lymphoma

ALK-negative Anaplastic Large Cell Lymphoma with Extensive Peripheral Blood and Bone Marrow Involvements Manifested As "leukemic Phase".

Expression of Anaplastic Lymphoma Kinase in Soft Tissue Tumors: an Immunohistochemical and Molecular Study of 249 Cases

Microrna Expression Profiling Identifies Molecular Signatures Associated with Anaplastic Large Cell Lymphoma

Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas

Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling

ALK and C-Myc Gene of Anaplastic Large Cell Lymphoma

Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma

Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion

ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern

Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma

ALCL by any other name: the many facets of anaplastic large cell lymphoma

Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma

[Genetic abnormality and protein expression of C-MYC and PD-L1 in ALK-negative anaplastic large cell lymphoma]

Clinical and Laboratory Characteristics of Systemic Anaplastic Large Cell Lymphoma in Chinese Patients

[Detection of Chromosomal Translocations Involving ALK Gene in Anaplastic Large Cell Lymphoma by Fluorescence In-Situ Hybridization and Its Clinical Significance].

The Histologic, Immunohistochemical, and Genetic Features of Classical Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma with Aberrant T-cell/B-cell Antigen Expression.

Anaplastic lymphoma kinase fusion gene expression, clinical pathological characteristics and prognosis in 95 Chinese patients with non-small cell lung cancer]